Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Population Pharmacokinetics and Dosing Simulations of Pentobarbital in the Pediatric Population.
Journal: Journal of clinical pharmacology
Published: March 23, 2026
Toward Optimal Dosing in Systemic Lupus Erythematosus: The Case for Hydroxychloroquine Blood Level Monitoring.
Journal: Arthritis care & research
Published: January 29, 2026
Correction: Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10‑Monohydroxy Derivative to Inform Dosing in Children with Obesity.
Journal: Clinical pharmacokinetics
Published: January 06, 2026
Population Pharmacokinetics and Exposure-Safety Analysis of Furosemide in Preterm Infants.
Journal: Journal of clinical pharmacology
Published: December 18, 2025
External Evaluation of a Plasma and Cerebrospinal Fluid Population Pharmacokinetics Model of Meropenem in Infants.
Journal: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG
Published: October 13, 2025
Metronidazole exposure-response and safety in infants.
Journal: Antimicrobial agents and chemotherapy
Published: September 19, 2025
Erratum for Randell et al., "Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole".
Journal: Antimicrobial agents and chemotherapy
Published: July 25, 2025
Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 10, 2025
Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
Journal: Pediatric rheumatology online journal
Published: May 16, 2025
Population Pharmacokinetics of Alfentanil in Children.
Journal: Journal of clinical pharmacology
Published: March 04, 2025
Infliximab Pharmacokinetics, Dosing, and Response in Hospitalized Patients with COVID-19 Pneumonia: A Secondary Analysis of a Multinational Randomized Clinical Trial (ACTIV-1 IM).
Journal: Journal of clinical pharmacology
Published: February 13, 2025
Relationship between hydroxychloroquine blood levels and lupus activity through the lens of the type 1 and type 2 lupus model: a cross-sectional study.
Journal: Lupus science & medicine
Published: February 06, 2025
Last Updated: 09/26/2026